Crossref
Personalized mRNA Cancer Vaccine Reduces Melanoma Recurrence Risk
JAMA · 13.11.2026
DOI: 10.1001/jama.2026.20047 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA, online erschienen am 13.11.2026. Verfasst von Samantha Anderer.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Anderer, S. (2026). Personalized mRNA Cancer Vaccine Reduces Melanoma Recurrence Risk. JAMA. https://doi.org/10.1001/jama.2026.20047
Vancouver
Anderer S. Personalized mRNA Cancer Vaccine Reduces Melanoma Recurrence Risk. JAMA. 2026. doi:10.1001/jama.2026.20047
BibTeX
@article{Anderer2026,
author = {Anderer, Samantha},
title = {Personalized mRNA Cancer Vaccine Reduces Melanoma Recurrence Risk},
journal = {JAMA},
year = {2026},
doi = {10.1001/jama.2026.20047}
}
EUVIMED